Head-to-head · WeighScore
Eden vs ShedRx
By GLP-1 ScorecardUpdated
Score comparison
ShedRx has the higher recorded score — 87/100 to 81.6/100.
ShedRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Shed combines compounded injections and branded Wegovy/Zepbound options with coaching; compare longer-plan supply, fees and guarantee rules before committing.
Before you choose
Before comparing the headline prices, the Eden review and the ShedRx review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Eden vs TD Tele-Doc Weight Loss and Eloria vs ShedRx compare each of them with another graded program, and the list of alternatives to Eden ranks the programs closest to Eden on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Eden | ShedRx |
|---|---|---|
| WeighScore | 81.6/100 | 87/100 |
| Grade | B− | B+ |
| Site position | #16 | #3 |
| Semaglutide | Advertised $99/mo bundle; linked membership terms conflict—confirm checkout | $199/mo |
| Tirzepatide | Advertised $129/mo bundle; linked membership terms conflict—confirm checkout | $299/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Yes |
Site position #16 · B−
FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.
Strengths
- Current compounded offer includes medication and support
- Homepage also advertises branded prescription pathways; eligibility and cost require confirmation
- Named pharmacy operation and partner network can be investigated
What to consider
- Linked membership terms describe a separate fee model
- Landing-page warranty and terms use different thresholds and conditions
- FDA warning history remains relevant; a new offer does not establish resolution
Site position #3 · B+
Strengths
- Published injection plans plus other formulation and branded prescribing options
- One-month injection prices listed at $199 semaglutide / $299 tirzepatide
- Terms describe monthly coaching and name six possible pharmacy partners
What to consider
- Six- and twelve-month plans specify 24 and 48 weeks of medication
- The 120-day promise has first-time-user and participation requirements and does not cancel a longer plan
- Branded pages display conflicting $99/$125 membership charges, with medication separate
- Actual clinician/pharmacy assignment and the applicable minimum term need confirmation
Featured provider
ShedRx
ShedRx scores 87/100 (B+). Shed combines compounded injections and branded Wegovy/Zepbound options with coaching; compare longer-plan supply, fees and guarantee rules before committing.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.